Drugs / PCP-PBMCs
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT07703280 | Sep 2026 → Dec 2028 expected | osteoarthritis, knee | DuoGenic StemCells Corporation (DGSC) | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PCP-PBMCs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07703280 ↗ |
| Modality | Cell therapy | “autologous peripheral blood mononuclear cells (PBMCs)” NCT07703280 ↗ |
| Route | Other | “injection into synovial cavity” NCT07703280 ↗ |